Vynfinit (vintafolide) - Novartis
Merck: Annual Report 2013 (Merck (MSD)) - Mar 19, 2014 - Anticipated patent expiry in US in 2024
 
Anticipated patent expiry • Ovarian Cancer
http://www.merck.com/investors/financial-reports/home.html
 
Mar 19, 2014
 
.